Business Wire

Pulmonx Announces that Priority Health Now Covers the Zephyr Valve, a Less Invasive Treatment Option for Severe Emphysema (COPD)

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Pulmonx Corporation, a leader in therapeutic pulmonary device technologies, announced today that its Zephyr® Valve is now covered by Priority Health® under its ...
Nasdaq

Pulmonx Announces Additional 16 Million Covered Lives for The Zephyr® Valve, a Minimally Invasive Treatment Option for Severe Emphysema (COPD)

Positive Coverage Policy from Health Care Service Corporation (HCSC) Covers Blue Cross Blue Shield Members in Illinois, Montana, New Mexico, Oklahoma and Texas REDWOOD CITY, Calif., Nov. 02, 2020 ...
Business Wire

Pulmonx® Announces 10,000 Patients Treated with Zephyr® Endobronchial Valves To-Date

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Pulmonx®, a leader in interventional pulmonology, today announced that 10,000 patients have been treated to-date with its Zephyr® Endobronchial Valve (EBV). The ...
Nasdaq

Zephyr® Valve Treatment Provides Long-Term Quality of Life and Lung Function Improvements for Patients with Severe COPD/Emphysema

New Data Presented at ATS 2021 International Conference Shows Positive, Sustained Benefits to Patients Treated with this First Minimally Invasive, Non-drug Treatment Option REDWOOD CITY, Calif., May ...